Baker Bros. Advisors Lp, Ten Percent Owner at BioCryst, holds 425.01K shares in Kala Pharmaceuticals (Ticker: KALA), holds 28.78M shares in Incyte (Ticker: INCY), holds 7.21M shares in Celcuity (Ticker: CELC). Most recently, Baker Bros. Advisors Lp Sold ― shares of Kala Pharmaceuticals on Oct 02, 2025 for an estimated value of $1.05M.
What was Baker Bros. Advisors Lp’s latest transaction?
Baker Bros. Advisors Lp latest transaction was an Informative Sell of $1.05M.
What was Baker Bros. Advisors Lp's most profitable transaction?
Baker Bros. Advisors Lp’s most profitable transaction was an Informative Buy of NVTAQ stock on March 29, 2018. The return on the trade was 399.30%.
What is Baker Bros. Advisors Lp's role in BioCryst?
Baker Bros. Advisors Lp's role in BioCryst is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.